Notably, miR-361-5p inhibits autophagy by suppressing the Sp1/PKM2 signaling, consequently affecting the proliferation and metabolism of PCa cells, which is a potential target in PCa therapy. This evidence concerns the gene SP1 and posterior cortical atrophy.